387 related articles for article (PubMed ID: 17021801)
1. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
Tarasov AI; Girard CA; Larkin B; Tammaro P; Flanagan SE; Ellard S; Ashcroft FM
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():46-55. PubMed ID: 17919178
[TBL] [Abstract][Full Text] [Related]
3. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
Tammaro P; Girard C; Molnes J; Njølstad PR; Ashcroft FM
EMBO J; 2005 Jul; 24(13):2318-30. PubMed ID: 15962003
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
[TBL] [Abstract][Full Text] [Related]
6. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
Shimomura K; de Nanclares GP; Foutinou C; Caimari M; Castaño L; Ashcroft FM
Diabet Med; 2010 Feb; 27(2):225-9. PubMed ID: 20546268
[TBL] [Abstract][Full Text] [Related]
7. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
Tammaro P; Proks P; Ashcroft FM
J Physiol; 2006 Feb; 571(Pt 1):3-14. PubMed ID: 16339180
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
Proks P; Girard C; Ashcroft FM
Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
Reimann F; Tucker SJ; Proks P; Ashcroft FM
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
[TBL] [Abstract][Full Text] [Related]
10. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
12. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
13. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.
Proks P; Shimomura K; Craig TJ; Girard CA; Ashcroft FM
Hum Mol Genet; 2007 Aug; 16(16):2011-9. PubMed ID: 17584766
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
[TBL] [Abstract][Full Text] [Related]
17. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
Shimomura K; Girard CA; Proks P; Nazim J; Lippiat JD; Cerutti F; Lorini R; Ellard S; Hattersley AT; Barbetti F; Ashcroft FM
Diabetes; 2006 Jun; 55(6):1705-12. PubMed ID: 16731833
[TBL] [Abstract][Full Text] [Related]
18. Altered functional properties of KATP channel conferred by a novel splice variant of SUR1.
Sakura H; Trapp S; Liss B; Ashcroft FM
J Physiol; 1999 Dec; 521 Pt 2(Pt 2):337-50. PubMed ID: 10581306
[TBL] [Abstract][Full Text] [Related]
19. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
